Tianlu Huang
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.
Journal: American journal of cancer research
Published: September 23, 2023
A Design Method of Traveling Wave Rotary Ultrasonic Motors Driving Circuit under High Voltage Using Single-Sided Hertzian Contact Forced Oscillator Model.
Journal: Micromachines
Published: November 28, 2022
CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263.
Journal: Cell death & disease
Published: March 21, 2019
BRD4 degrader ARV-825 produces long-lasting loss of BRD4 protein and exhibits potent efficacy against cholangiocarcinoma cells.
Journal: American journal of translational research
Published: February 17, 2019
Gastrointestinal: A case of spontaneous rupture of esophageal diverticulum.
Journal: Journal of gastroenterology and hepatology
Published: January 26, 2019
Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.
Journal: American journal of cancer research
Published: January 05, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026